Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIMREATOX digestive decontamination study in severe drug poisoning
2024-518739-12-00Phase 2Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2026
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of macrogol in drug intoxication (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Percentage change in plasma toxicant concentration at 24 hours. Planned start Jun 2026; status: authorised.
02
Drugs
macrogol
03
Conditions
drug intoxication
Beyond the preview
Go deeper on 2024-518739-12-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518739-12-00.